SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PRETI, Delia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.379
EU - Europa 3.280
AS - Asia 2.298
SA - Sud America 382
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 14.371
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.338
DE - Germania 1.179
CN - Cina 888
SG - Singapore 778
IT - Italia 534
UA - Ucraina 489
TR - Turchia 380
BR - Brasile 345
GB - Regno Unito 284
RU - Federazione Russa 229
SE - Svezia 187
FI - Finlandia 175
VN - Vietnam 70
PL - Polonia 58
HK - Hong Kong 56
BE - Belgio 44
ID - Indonesia 36
CA - Canada 33
FR - Francia 25
NL - Olanda 25
IN - India 17
PK - Pakistan 15
CZ - Repubblica Ceca 12
IQ - Iraq 11
ZA - Sudafrica 11
AR - Argentina 10
KR - Corea 9
LT - Lituania 9
AT - Austria 7
CL - Cile 6
EU - Europa 6
CO - Colombia 5
EC - Ecuador 5
ES - Italia 5
IL - Israele 5
TN - Tunisia 5
UZ - Uzbekistan 5
BD - Bangladesh 4
JP - Giappone 4
KZ - Kazakistan 4
MX - Messico 4
PE - Perù 4
AU - Australia 3
IR - Iran 3
MA - Marocco 3
PY - Paraguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
GH - Ghana 2
IE - Irlanda 2
JO - Giordania 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 14.371
Salva come PNG Salva come JPEG
Città #
Fairfield 1.100
Woodbridge 1.035
Ann Arbor 606
Ashburn 578
Houston 534
Jacksonville 531
Chandler 500
Santa Clara 429
Seattle 422
Wilmington 401
Singapore 376
Cambridge 338
Ferrara 239
Izmir 182
Beijing 178
Nanjing 153
Princeton 131
Boardman 120
San Diego 108
Shanghai 101
Milan 75
Helsinki 65
Dong Ket 64
Warsaw 58
Bremen 57
Hong Kong 54
Los Angeles 52
Nanchang 50
Shenyang 50
Brussels 44
New York 41
Munich 38
Tianjin 36
Dearborn 35
Jakarta 35
San Mateo 32
Changsha 31
Falkenstein 31
London 31
Hebei 30
Falls Church 27
Jiaxing 27
Redwood City 27
Mountain View 25
Addison 20
São Paulo 20
Philadelphia 18
Zhengzhou 18
Frankfurt am Main 17
Guangzhou 17
Washington 17
Kunming 16
Toronto 16
Jinan 15
Auburn Hills 14
Duncan 13
Indiana 13
Norwalk 12
Orange 12
Belo Horizonte 11
Bologna 11
Brasília 11
Des Moines 11
Ferrara di Monte Baldo 11
Amsterdam 10
Nuremberg 10
Rio de Janeiro 10
Tappahannock 10
Council Bluffs 9
Ottawa 9
Padova 9
Bari 8
Brno 8
Espoo 8
Kilburn 8
Mcallen 8
Montréal 8
Rome 8
Ningbo 7
Verona 7
Chicago 6
Haikou 6
Hangzhou 6
Lanzhou 6
Naples 6
Taunsa 6
The Dalles 6
Buenos Aires 5
Cotia 5
Curitiba 5
Florence 5
Guarulhos 5
Prescot 5
Sorocaba 5
Augusta 4
Baghdad 4
Düsseldorf 4
Grassano 4
Karachi 4
Lima 4
Totale 9.608
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 369
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 217
A3 adenosine receptor antagonists: History and future perspectives 163
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 160
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 157
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 156
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 156
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 156
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 155
DNA minor groove binders as potential antitumor and antimicrobial agents 154
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 152
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 152
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 147
Hybrid molecules based on distamycin A as potential antitumor agents 147
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 146
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 146
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 145
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 145
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 144
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 143
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 142
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 142
The involvement of the TRPA1 receptor in a mouse model of sympathetically maintained neuropathic pain 141
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 140
The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives 140
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 139
Recent improvements in the development of A2B adenosine receptor agonists 138
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 137
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 137
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 136
The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice 135
Allosteric enhancers for A(1) adenosine receptor 134
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 134
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation 134
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 133
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 132
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 131
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach 131
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 130
Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents 130
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents 130
Recent improvements in the development of A2B adenosine receptor agonists 129
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 128
Activation of TRPA1 on dural afferents: a potential mechanism of headache pain 127
Neuropeptide S receptor ligands: a patent review (2005-2016) 126
Hybrid molecules between distamycin A and active moieties of antitumor agents 126
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 124
Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications 124
null 124
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked heterocycles as template for the adenosine receptor antagonism: medicinal chemistry approach and SAR considerations. 123
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 122
Ozone-induced hypertussive responses in rabbits and guinea pigs 122
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents 121
null 121
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 121
Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as Emerging Target for Novel Analgesics and Anti-Inflammatory Agents 120
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 120
null 120
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 118
null 118
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 117
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 117
Recent developments in the field of adenosine receptor ligands. 116
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 115
The P2X7 receptor as a therapeutic target. 113
null 112
The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system. 112
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 112
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 112
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 111
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 111
null 110
null 109
Synthesis and biological evaluation of 2-substituted-4-(3 ',4 ',5 '-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents 107
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 105
New strategies for the synthesis of A(3) adenosine receptor antagonists 105
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 104
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 104
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 104
null 103
Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agents 102
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 101
TRP channels as therapeutic targets in airway disorders: a patent review 100
Adenosine Modulates HIF-1 alpha, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells 98
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 97
Preparation of fused purine derivatives as adenosine A3 receptor modulators. 96
Preparation of fused purine derivatives as adenosine A3 receptor modulators. 96
null 96
Role of TRPA1 receptors in skin inflammation induced by volatile chemical irritants in mice 95
The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channel 94
Recent developments in the field of A2B and A3 adenosine receptors antagonists 93
Recent improvements in the field of A(3) adenosine receptor ligands 93
alpha-Halogenoacrylic Derivatives of Antitumor Agents 93
Design, synthesis and biological evaluation of hybrid molecules containing conjugated styryl ketone and α-bromoacryloyl moieties 92
null 92
Adenosine in a human model of Hypoxic foam cells 91
Ligands for A(2B) adenosine receptor subtype 89
New pyrrolo [2,1-f] purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione derivates as potent and selective human A3 adenosine receptor antagonists 89
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 89
null 87
Totale 12.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.801
Totale 70.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020188 0 0 0 0 0 0 0 0 0 0 141 47
2020/20211.854 183 134 91 184 85 183 83 217 59 281 186 168
2021/20221.365 62 127 137 55 88 61 84 57 47 105 140 402
2022/20231.270 132 86 23 181 239 171 53 92 169 9 64 51
2023/2024831 59 96 49 25 60 137 41 90 25 19 22 208
2024/20252.416 85 99 271 144 350 322 103 194 474 348 26 0
Totale 14.566